ArticleCurrent microbiology2025
Coexpression of the Ectoine Biosynthetic Gene Cluster from Nocardiopsis dassonvillei NCIM 5124 in Escherichia coli by Using a Novel Strategy.
Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Synthesis and Biological Activity Characterization of Vascular Endothelial Growth Factor Using an Optimized Wheat Germ Cell-Free System.Current issues in molecular biology · 2026Article
- Molecular basis of heavy metal tolerance in the marine actinomycete Nocardiopsis dassonvillei NCIM 5124.World journal of microbiology & biotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Ectoine, a natural cell protectant produced by a variety of bacteria has commercial value. In this study, Escherichia coli BL21(DE3) was engineered for producing ectoine by using a novel approach. The ectABC gene cluster from Nocardiopsis dassonvillei NCIM 5124 was codon optimized for E. coli and a pET-24a(+) based construct (pEctoineCAB) was designed. Two elements-P2A tag (derived from porcine teschovirus-1 that causes ribosomal skipping) and IRES sequence (internal ribosome entry site from encephalomyocarditis virus) were introduced to ensure sufficient expression levels of all the enzymes relevant to ectoine production. The ability of the transformant harbouring pEctoineCAB was evaluated for its ectoine biosynthetic capability. In the presence of 0.1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) as an inducer, 31.52 mg/g cell dry weight (CDW) of ectoine was obtained. After inclusion of 200 mM L-aspartic acid as precursor, this content was further enhanced to 131.41 mg/g CDW. With the acquired ability to produce ectoine, the recombinant strain tolerated sodium chloride (NaCl) up to a level of 5%. Compared to the original organism that produced 40.78 mg/g CDW of ectoine after 48 h in medium containing 5% NaCl, the recombinant produced higher content of ectoine (131.41 mg/g CDW) after 24 h of incubation in the absence of salt. On account of these features, the process of ectoine production by the recombinant was deemed effectual and economically lucrative for large-scale production. This is the first report on the use of P2A tag in E. coli for effective production of an economically important product.
Indexed as
Identifiers
40965678What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.